Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review

Lung, Respiratory and Thoracic Cancer

Efficacy and safety of targeted therapy combined with anti-angiogenesis treatment in brain metastases of non-small cell lung cancer: a systematic review and meta-analysis

Lung Cancer

Pan Y, Gu Q

doi: 10.1016/j.lungcan.2025.108532

Genitourinary Cancer

First-Line Therapy For Advanced Non-Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

JAMA Oncol

Petrelli F, Verri E, Ghidini A, Vavassori I, Lonati V, Nolè F, Dottorini L

doi: 10.1001/jamaoncol.2025.1891

Genitourinary Cancer

Spontaneous regression of metastatic clear cell renal cell carcinoma: A report of a rare case and a review of the literature

Urol Case Rep

Mullasseril A, Lam AB, Mitta A, Morton D, McIntosh A, Patel S, Thai T, Annan A, Ayanambakkam A

doi: 10.1016/j.eucr.2024.102868

Genitourinary Cancer

Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis

Lancet Oncol

Huang RS, Chow R, Benour A, Chen D, Boldt G, Wallis CJD, Swaminath A, Simone CB 2nd, Lock M, Raman S

doi: 10.1016/S1470-2045(24)00731-9

Further Publications

Frailty and outcomes in adults undergoing systemic anti-cancer treatment: a systematic review and meta-analysis

J Natl Cancer Inst

Pearce J, Martin S, Heritage S, Khoury EG, Kucharczak J, Nuamek T, Cairns DA, Velikova G, Richards SH, Clegg A, Gilbert A

doi: 10.1093/jnci/djaf017

Genitourinary Cancer

Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial

Int J Cancer

Grünwald V, McKay RR, Buchler T, Eto M, Park SH, Takagi T, Zanetta S, Keizman D, Suárez C, Négrier S, Lee JL, Santini D, Bedke J, Staehler M, Kollmannsberger C, Choueiri TK, Motzer RJ, Burgents JE, Xie R, Okpara CE, Powles T

doi: 10.1002/ijc.35288

Genitourinary Cancer

Avelumab + axitinib vs sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase 3 JAVELIN Renal 101 trial

Ann Oncol

Choueiri TK, Penkov K, Uemura H, Campbell MT, Pal S, Kollmannsberger C, Lee JL, Venugopal B, van den Eertwegh AJM, Negrier S, Gurney H, Albiges L, Berger R, Haanen JBAG, Oyervides Juárez V, Rini BI, Larkin J, Nolè F, Schmidinger M, Atkins MB, Tomita Y, Ellers-Lenz B, Hoffman J, Sandner R, Wang J, di Pietro A, Motzer RJ

doi: 10.1016/j.annonc.2024.12.008

Genitourinary Cancer

Determinants of late metastases in renal cell carcinoma

J Natl Cancer Inst

Kapur P, Zhong H, Christie A, Xu H, Cai Q, Araj E, Kim D, Miyata J, Tcheuyap VT, Ball CT, Thiel DD, Parker A, Antwi SO, Leibovich BC, Modrusan Z, Cheville JC, Brugarolas J

doi: 10.1093/jnci/djaf060

Genitourinary Cancer

Secondary malignancies after treatment of testicular germ cell tumors: a systematic review & meta-analysis

J Natl Cancer Inst

Mousa A, Amiri A, Kaushal S, Wilson E, Jayalath V, Nguyen DD, Tan I, Hamilton RJ

doi: 10.1093/jnci/djaf099

Related content

Efficacy and safety of targeted therapy combined with anti-angiogenesis treatment in brain metastases of non-small cell lung cancer: a systematic review and meta-analysis

First-Line Therapy For Advanced Non-Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

Spontaneous regression of metastatic clear cell renal cell carcinoma: A report of a rare case and a review of the literature

Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis

Frailty and outcomes in adults undergoing systemic anti-cancer treatment: a systematic review and meta-analysis

Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial

Avelumab + axitinib vs sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase 3 JAVELIN Renal 101 trial

Determinants of late metastases in renal cell carcinoma

Secondary malignancies after treatment of testicular germ cell tumors: a systematic review & meta-analysis